Skip to main content
BPH ENERGY LTD logo

BPH ENERGY LTD — Investor Relations & Filings

Ticker · BPH ISIN · AU000000BPH4 ASX Financial and insurance activities
Filings indexed 1,483 across all filing types
Latest filing 2004-09-28 Annual Report
Country AU Australia
Listing ASX BPH

About BPH ENERGY LTD

https://www.bphenergy.com.au/

BPH Energy Ltd is a diversified investment company focused on the commercialization of biomedical technologies and the exploration of energy resources. The company maintains a significant portfolio in the biotechnology sector, notably through its investment in Cortical Dynamics Ltd, which develops the Brain Anaesthesia Response Monitor (BARM) for objective measurement of anesthetic effect. In the energy sector, BPH Energy holds a substantial interest in Advent Energy Ltd, an unlisted oil and gas exploration company with assets including the PEP 11 permit in the offshore Sydney Basin. Additionally, the company has expanded its focus into sustainable energy through investments in Clean Hydrogen Technologies, which utilizes proprietary processes to produce turquoise hydrogen and solid carbon. BPH Energy aims to identify and develop high-growth opportunities within the healthcare and resource sectors to create long-term value.

Recent filings

Filing Released Lang Actions
Full Year Accounts 27 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2004' for BioPharmica Ltd and contains detailed sections typical of an annual report, including Chairman's Letter, Company Focus and Developments, Corporate Governance, Directors' Report, Independent Audit Report, Directors' Declaration, and full financial statements such as Statement of Financial Performance, Position, Cash Flows, and Notes. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content covers comprehensive company activity, financial performance, governance, and strategic outlook for the fiscal year 2004. These characteristics align with the definition of an Annual Report (10-K). FY 2004
2004-09-28 English
Shareholder Non-Renounceable Option Notice 2 pages ?Kb
Regulatory Filings
2004-09-27 English
Short Form Prospectus: Non renounceable options rights issue 26 pages ?Kb
Regulatory Filings
2004-09-26 English
Appendix 3B: Working Capital and Issue Expenses 8 pages ?Kb
Regulatory Filings
2004-09-26 English
Brain Science Company Signs With BioPharmica 3 pages ?Kb
Regulatory Filings
2004-09-26 English
Swinburne Uni & BioPharmica Biotech Agreement 2 pages ?Kb
Regulatory Filings
2004-09-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.